Revenue ($USD) : $407,856,000
R&D spend : $68,645,000.00
Employees : 755
Fiscal year end : 12/31/22
CEO : Tim Herbert

Inspire Medical Systems revenue grew nearly 74% year-over-year during the first half of 2023, with the implantable sleep apnea device company expecting full-year growth in the 47% to 50% range. Inspire’s pacemaker-like device that provides an alternative therapy to CPAPs has benefited from the Philips recall. Most recently, Inspire hired former Medtronic VP and Spine & Biologics GM Carlton Weatherby as its chief strategy officer and former Applied VR executive Dr. Charisse Sparks as chief medical officer. –CN